当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pound foolish and penny wise—when will dosing of rifampicin be optimised?
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2018-01-29 , DOI: 10.1016/s2213-2600(18)30044-4
Cecile Magis-Escurra , Richard M Anthony , Adri G M van der Zanden , Dick van Soolingen , Jan-Willem C Alffenaar

In September, 2017, the authors attended a tuberculosis conference in China where it became clear that resistance to anti-tuberculosis drugs could render the ambitious WHO targets for tuberculosis elimination unreachable.
更新日期:2018-03-24
down
wechat
bug